Laura Luh

Laura Luh is an experienced professional in the biotechnology and pharmaceutical sectors, currently working at Bayer since September 2018 in various roles including Strategy & Portfolio Manager, Chief of Staff for R&D Strategy, Portfolio & Operations, Chemical Biology Lead, and Head of Laboratory for Lead Discovery. Prior experience includes a postdoctoral researcher position at the MRC Laboratory of Molecular Biology from June 2015 to December 2018, where Laura Luh focused on identifying potent Ser/Thr phosphatase inhibitors for neurodegenerative diseases. Additionally, a consultancy project was conducted with Qkine Ltd and the University of Cambridge in early 2018, exploring the commercialization potential of growth factors for regenerative medicine. Laura Luh began research career as a research scientist at Evotec from May 2014 to April 2015, following the attainment of a PhD in Biochemistry from Goethe University Frankfurt in 2014.